Vmbook Online ordering

Biotechnology

I am not a stock trading expert, but I can provide you with some general information about the biotechnology company with the stock symbol CLDN, which is CareDx, Inc. CareDx is a public company listed on the NASDAQ stock exchange.

Regarding its earnings and growth, here is some information:

Earnings:

* For the quarter ending September 30, 2021, CareDx reported revenue of $68.4 million, representing an increase of 32% year-over-year.

* The company's net income for the quarter was $13.2 million, or $0.31 per share, compared to a net loss of $2.2 million, or $0.06 per share, for the same period in the prior year.

Growth:

* CareDx has seen significant growth in its AlloSure and OkaSENSA testing services, which are used to detect and monitor organ transplant rejection.

* The company's revenue from its testing services increased by 42% year-over-year for the quarter ending September 30, 2021.

* CareDx also recently acquired OTTR, a provider of transplant patient data management software, which is expected to expand the company's product offerings and revenue streams.

Other information:

* CareDx was founded in 1998 and is headquartered in Brisbane, California.

* The company's main product offerings include non-invasive testing services and diagnostic products for organ transplant recipients.

* As of December 31, 2021, CareDx had a market capitalization of approximately $3.25 billion.

Note that the above information is subject to change and may not be up-to-date. It is recommended to consult the latest financial statements and company reports for the most accurate information.